Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiency
- 1 August 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (3), 337-344
- https://doi.org/10.1172/jci6092
Abstract
Traditional enzyme kinetics provide a poor explanation for the increased risk of lung injury in α1-antitrypsin (AAT) deficiency. Millimolar concentrations of leukocyte elastase, when released from single azurophil granules of activated neutrophils, lead to evanescent quantum bursts of proteolytic activity before catalysis is quenched by pericellular inhibitors. Herein, we tested the possibility that quantum proteolytic events are abnormal in AAT deficiency. We incubated neutrophils on opsonized fluoresceinated fibronectin in serum from individuals with various AAT phenotypes, and then measured and modeled quantum proteolytic events. The mean areas of the events in serum from heterozygous individuals (Pi MZ and Pi SZ) were slightly, but significantly, larger than those in serum from normal patients (Pi M). In marked contrast, mean areas of events in serum from AAT-deficient individuals were 10-fold larger than those in serum from normal patients. Diffusion modeling predicted that local elastase concentrations exceed AAT concentrations for less than 20 milliseconds and for more than 80 milliseconds in Pi M and Pi Z individuals, respectively. Thus, quantum proteolytic events are abnormally large and prolonged in AAT deficiency, leading directly to an increased risk of tissue injury in the immediate vicinity of activated neutrophils. These results have potentially important implications for the pathogenesis and prevention of lung disease in AAT deficiency.This publication has 51 references indexed in Scilit:
- Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEuropean Respiratory Journal, 1997
- Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiencyQJM: An International Journal of Medicine, 1996
- Nonisotropic Enzyme-Inhibitor Interactions: A Novel Nonoxidative Mechanism for Quantum Proteolysis by Human NeutrophilsBiochemistry, 1995
- The effect of the Z mutation on the ability of α1-antirtrypsin to prevent neutrophil mediated tissue damageBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Natural history of alpha-1-protease inhibitor deficiencyAmerican Journal Of Medicine, 1988
- Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with EmphysemaNew England Journal of Medicine, 1987
- Alpha1antitrypsin deficiency: Clinical and physiological features in heterozygotes of Pi types SZ: A survey by the British Thoracic AssociationRespiratory Medicine, 1983
- Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population.Thorax, 1976
- SERU Pi TYPES IN PATIENTS WITH PULMONARY DISEASESAllergy, 1969
- The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963